lonidamine has been researched along with Sepsis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, C; Cai, W; Chen, C; Ding, Y; Fu, Y; Huang, Y; Li, S; Li, Y; Lin, S; Lu, B; Ning, X; Sheng, L; Wei, C; Xue, D; Yan, G; Ye, X; Yin, W; Zhou, Y; Zhu, Z | 1 |
1 other study(ies) available for lonidamine and Sepsis
| Article | Year |
|---|---|
Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Humans; Inflammasomes; Mice; Multiple Sclerosis; NLR Family, Pyrin Domain-Containing 3 Protein; Sepsis | 2022 |